Medications for Early Stage Her2positive Breast Carcinoma

2 results

  • kadcyla - ado - trastuzumab emtansine injection, powder, lyophilized, for solution

    (Ado-Trastuzumab Emtansine)
    Genentech, Inc.
    Kadcyla treats HER2-positive metastatic breast cancer in adults who previously received trastuzumab and a taxane, and is used adjuvantly in HER2-positive early breast cancer patients with residual invasive disease after neoadjuvant taxane and trastuzumab-based treatment.
    Medication Details
    Drug Interactions

  • perjeta - pertuzumab injection, solution, concentrate

    (Pertuzumab)
    Genentech, Inc.
    Perjeta is used with trastuzumab and chemotherapy to treat HER2-positive breast cancer in adults. Indicated for metastatic breast cancer without prior anti-HER2 therapy, neoadjuvant treatment of locally advanced or early-stage breast cancer, and adjuvant treatment of early breast cancer at high risk of recurrence.
    Medication Details
    Drug Interactions